Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.

Peri-operative blood management. Indian J Anaesth (2017) 0.75

The expanding role of tranexamic acid in the management of obstetric hemorrhage. J Thorac Dis (2017) 0.75

Maternal mortality: who, when, where, and why. Lancet (2006) 21.46

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet (2010) 10.21

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet (2011) 9.31

Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health (2014) 7.11

Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. N Engl J Med (2016) 4.58

Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ (2012) 3.05

Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res (2009) 2.07

Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol (2008) 1.82

The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials (2010) 1.74

Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg (2013) 1.70

When getting there is not enough: a nationwide cross-sectional study of 998 maternal deaths and 1451 near-misses in public tertiary hospitals in a low-income country. BJOG (2015) 1.60

Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood (1987) 1.29

Socio-demographic characteristics and the three delays of maternal mortality. J Coll Physicians Surg Pak (2009) 1.18

CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials (2012) 1.04

Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients. J Trauma Acute Care Surg (2016) 0.93

HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial. Trials (2014) 0.88

Dangers of non-specific composite outcome measures in clinical trials. BMJ (2013) 0.87

Postpartum haemorrhage related early increase in D-dimers is inhibited by tranexamic acid: haemostasis parameters of a randomized controlled open labelled trial. Br J Anaesth (2016) 0.85

Procoagulant and fibrinolytic activity after polytrauma in rat. Am J Physiol Regul Integr Comp Physiol (2015) 0.82

The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial. Trials (2016) 0.79

Factors associated with postpartum hemorrhage maternal death in referral hospitals in Senegal and Mali: a cross-sectional epidemiological survey. BMC Pregnancy Childbirth (2015) 0.78

Post-partum haemorrhage and the WOMAN trial. Int J Epidemiol (2010) 0.78